Precision Medicine Pioneer
We’re About Improving Lives — As Many as Possible
Caris Life Sciences was founded in 2008 with the belief and vision that combining a vast set of consistently generated molecular information with robust data-driven insights could realize the potential of precision medicine for patients. With transformative technologies informed by massive amounts of big data, we are revolutionizing healthcare to provide physicians and patients with the highest quality information about their disease – from detecting it early and determining how best to treat it, to developing the next wave of novel therapies.
Caris was built for one reason — to improve the human condition. Through tireless efforts, breakthrough molecular science, and a passionate commitment to quality, we remain steadfastly focused on the most important part of our work — the patient.”
-David Dean Halbert, DSc (h.c.), Chairman, Founder and CEO
Unlocking Disease to Improve the Human Condition
The root cause for nearly every type of disease is that an error has occurred somewhere in the human body. Nested deep in our molecular coding, is a universe of biological networks that provide the source of life. From how our cells grow, divide and even die, this biological web holds the keys to better detect, categorize, treat and inform healthcare in an entirely new way.
Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris has created the large-scale clinico-genomic database and cognitive computing needed to analyze and unravel the molecular complexity of disease. This convergence of sequencing power, big data and AI technologies provides an unmatched resource to develop the next-generation of precision medicine tools for early detection, diagnosis, monitoring, therapy selection and drug development.
Pioneering Precision Medicine Beyond Cancer
With a primary focus on cancer, Caris has built a market-leading portfolio of precision medicine tools that have helped more than half a million cancer patients worldwide. Caris’ patient impact, as well as molecular knowledge of disease, has significantly vaulted the field of Oncology from an empiric medicine methodology to a precision medicine approach. Oncology is now widely recognized as one of the most genomically characterized fields in medicine and nearly every clinical trial for cancer includes a biomarker or molecular signature to evaluate drug performance.
The information provided by Caris comprehensive molecular profiling is driving a revolution in medicine, where molecular information is used to guide individualized patient diagnoses and treatment. Beyond oncology, this precision medicine approach has applications across a wide range of disease areas, including cardiology, neurology, and metabolic conditions, among other chronic diseases.
Discover
More
Meet the leadership team working to deliver on the promise of precision medicine.
Read the latest news and press releases to stay up to date with the innovative work of Caris.